Clinical Trial Update: A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety and feasibility of C-CAR168 for CNS autoimmune diseases. The study is not yet recruiting and targets Mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis
• Multiple Sclerosis
• Neuromyelitis Optica Spectrum Disorder
• Stiff-person Syndrome

Drugs mentioned

• C-CAR168

Snippet

Sponsor: Huashan Hospital | Conditions: Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorders (NMOSD) | Phase 1 | Status: NOT_YET_RECRUITING